The cardiotoxic effects are mediated, at least in part, through inhibition of PDGFR-β; microscopic findings compatible with toxin-induced myopathy and mitochondrial damage are present in endomyocardial biopsies from patients with sunitinib-induced heart failure [30]. Here, PDGFRB is linked to heart failure.